Immune Checkpoint Inhibitors Linked to Heart Inflammation
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, opening new horizons in the fight against malignancies by unleashing the immune ...
Tag: FDA Adverse Event Reporting System
Global Study Finds CAR-T Cell Therapy Associated with Elevated Risk of Secondary Primary Malignancies
In recent years, chimeric antigen receptor T-cell (CAR-T) therapy has emerged as a transformative approach to treating refractory hematologic malignancies. ...
Safety of Pemetrexed, Platinum ± Pembrolizumab
In the evolving landscape of lung cancer treatment, the integration of immune checkpoint inhibitors (ICIs) with conventional chemotherapy regimens has ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!